首頁
SAB Biotherapeutics

7月 2026SAB Biotherapeutics的市場佔有率分析

SIOUX FALLS, S.D.--(BUSINESS WIRE)--SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibody therapeutics, today announced that Eddie J. Sullivan, PhD, co-founder, president and CEO, will present at the Ladenburg Thalmann Annual Healthcare Conference on Tuesday, July 13 at 5:00 p.m. ET.

行業: N/A

域名sabbiotherapeutics.com

成立年份2014

僱員51 - 200

年度營收$25M - $50M

SAB Biotherapeutics

SAB Biotherapeutics（包含公司地區）

sabbiotherapeutics.com

查看更多網站流量與參與度資訊

SAB Biotherapeutics截至 7月 2026 的總收入為 25M - 50M

SAB Biotherapeutics 熱門網域產生的總收入

SAB Biotherapeutics 熱門網域 3 年內的總收入

SAB Biotherapeutics 熱門網域的總收入

sabbiotherapeutics.com25M - 50M

透過銷售情報查看更多內容

SAB Biotherapeutics的熱門網域總造訪量

了解SAB Biotherapeutics市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

無可顯示數據

SAB Biotherapeutics的熱門網域平均造訪時長

分析SAB Biotherapeutics參與度指標。

過去 3 個月平均造訪時長

無可顯示數據

SAB Biotherapeutics的熱門網域平均頁面瀏覽量

了解SAB Biotherapeutics如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

無可顯示數據

SAB Biotherapeutics按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

使用的熱門技術SAB Biotherapeutics

这些是SAB Biotherapeutics顶级域名使用的行业网站技术

內容管理系統 (2)

WordPress

行動裝置 (2)

Meta Viewport

小工具 (2)

Google Maps

付費廣告 (1)

PubMatic

更多技術

6

檢視所有

新聞與訊號來自SAB Biotherapeutics

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞SAB Biotherapeutics, Inc. will attend event 2026 Scientific Sessions on Jun 5th '26.SAB BIO will present an oral presentation at the 2026 Scientific Sessions of the American Diabetes Association(R)(ADA) being held June 5-8, 2026, in New Orleans, LA.

新聞SAB Biotherapeutics, Inc. attends event Guggenheim Securities Emerging Outlook: Biotech Summit.SAB Biotherapeutics (Nasdaq: SABS) announced that management will participate in two investor conferences in February 2026: Guggenheim Securities Emerging Outlook: Biotech Summit on February 11, 2026 (10:30 a.m. ET, New York) and Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026 (8:40 a.m. ET, virtual).

新聞SAB Biotherapeutics, Inc. attends event International Society for Pediatric and Adolescent Diabetes Annual Conference.SAB BIO to present data at the International Society for Pediatric and Adolescent Diabetes Annual Conference showcasing progress in the development of SAB-142.